´ëÇѽÉÀåÇÐȸ ¿µÈ£³².ÁߺΠ¼øȯ±âÇÐȸ ¿¬¼ö°Á : 2019-06-29±³À°ÀÏÀÚ : 2019-06-29
±³À°Àå¼Ò : ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ
±³À°ÁÖÁ¦ :
¿µÈ£³².ÁߺΠ¼øȯ±âÇÐȸ ¿¬¼ö°ÁÂÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ºÎ¿ï°æÁöȸ
´ã´çÀÚ : Á¶º°
¿¬¶ôó : 051-890-8676
À̸ÞÀÏ :
cvcenter@hanmail.net ±³À°Á¾·ù : ³»°úÀÇ»çÇÐ, ÀÇÇб³À°, ÀÇ·áÁ¤Ã¥
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
ºÎ»ê±¤¿ª½Ã±³À°½Ã°£ : 6 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 10:10~10:30 The Updated Role of Aspirin for Primary Prevention of ASCVD ¹Ú¿ëÈÖ(°æ»óÀÇ´ë)
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 10:30~10:50 New Lipid-Lowering Guidelines: Goals and Strategies to Improve Outcomes °»ó¿í(´ë±¸º¸Èƺ´¿ø)
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 10:50~11:10 How to Approach to and Manage Resistant Hypertension ±è¼ÛÀÌ(Á¦ÁÖÀÇ´ë)
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 11:10~11:30 Review of Fourth universal definition of myocardial infarction ÃÖ¿õ±æ(°Ç±¹ÀÇ´ë)
Åä·Ð 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 11:30~11:50 discussion ´Ù°»ç(´Ù¼Ò¼Ó)
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 11:50~12:10 Ư° 1. The effect of evolocumab and its practical use Á¶¿ë¶ô(µ¿¾ÆÀÇ´ë)
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 12:10~12:30 Ư° 2. Translate Ticagrelor scientific evidence into clinical practice ÀåÀç½Ä(ÀÎÁ¦ÀÇ´ë)
½Ä»ç 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 12:30~13:00 Lunch ()
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 13:00~13:15 Timing and method of sinus conversion in Patients with AF and Heart Failure Á¤·¡¿µ(ÀüºÏÀÇ´ë)
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 13:15~13:30 How to treat Wolff-Parkinson-White syndrome? ¹ÚÁ¾¼º(µ¿¾ÆÀÇ´ë)
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 13:30~13:45 What Should We Know for ICD Therapy? ±èż®(Ä«Å縯ÀÇ´ë)
Åä·Ð 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 13:45~14:00 discussion ´Ù°»ç(´Ù¼Ò¼Ó)
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 14:00~14:15 Echocardiographic evaluation and management of Ascending Aortic Aneurysm ±èÀÎö(°è¸íÀÇ´ë)
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 14:15~14:30 How to manage severe secondary Tricuspid Regurgitation? ÀåÁ¤À±(°æ»óÀÇ´ë)
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 14:30~14:45 How to Use Cardiac Imaging for Therapeutic Approach in HF À±ÇöÁÖ(Àü³²ÀÇ´ë)
Åä·Ð 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 14:45~15:00 discussion ´Ù°»ç(´Ù¼Ò¼Ó)
ÈÞ½Ä 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 15:00~15:15 Coffee break and Exhibition Tour ()
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 15:15~15:30 Vasopressors versus Inotropes: How to choose in Various Situations of HF? ÀÌÁÖÈñ(ÃæºÏÀÇ´ë)
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 15:30~15:45 Cardiorenal syndrome: A Review À̼ö¿ë(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 15:45~16:00 What Should We Know for CRT Therapy? À±³²½Ä(Àü³²ÀÇ´ë)
Åä·Ð 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 16:00~16:15 discussion ´Ù°»ç(´Ù¼Ò¼Ó)
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 16:15~16:30 Management of stable angina : An update ¹Ú±ÙÈ£(Á¶¼±ÀÇ´ë)
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 16:30~16:45 Femoro-popliteal intervention ¹Ú»óÈ£(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 16:45~17:00 Interventional therapy for valvular heart disease ÀÌöÇö(°è¸íÀÇ´ë)
Åä·Ð 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 17:00~17:15 discussion ´Ù°»ç(´Ù¼Ò¼Ó)